佛慈制药涨2.08%，成交额1972.44万元，主力资金净流出82.72万元

Group 1 - The core viewpoint of the news is that Lanzhou Foci Pharmaceutical Co., Ltd. has experienced fluctuations in stock price and trading activity, with a year-to-date increase of 14.56% and a recent trading volume indicating mixed investor sentiment [1][2] - As of December 19, the stock price reached 8.83 yuan per share, with a market capitalization of 4.509 billion yuan and a trading volume of 19.7244 million yuan [1] - The company has seen a net outflow of main funds amounting to 827,200 yuan, with significant buying and selling activity from large orders [1] Group 2 - Lanzhou Foci Pharmaceutical was established on June 28, 2000, and listed on December 22, 2011, focusing on the research, production, and sales of traditional Chinese medicine and health products [2] - The company's main business revenue composition includes 99.41% from traditional Chinese medicine, medicinal materials, and protective products, with minor contributions from packaging materials and health foods [2] - As of September 30, the number of shareholders increased to 33,300, with an average of 15,340 circulating shares per person, indicating a slight decrease in individual shareholding [2] Group 3 - The company has distributed a total of 180 million yuan in dividends since its A-share listing, with 46.9804 million yuan distributed over the past three years [3]